Gfi1 as a regulator of p53 and a therapeutic target for ALL
Gfi1 as a regulator of p53 and a therapeutic target for ALL |
|
https://doi.org/10.18632/oncotarget.933
Cyrus Khandanpour,
and Tarik Möröy
|
| 374-375 |
Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition |
|
https://doi.org/10.18632/oncotarget.919
Clémence Thomas,
and Antoine E. Karnoub
|
| 376-377 |
Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma?
Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma? |
|
https://doi.org/10.18632/oncotarget.937
Brenda Auffinger,
Ramin Morshed,
Alex Tobias,
Yu Cheng,
Atique U Ahmed,
and Maciej S Lesniak
|
| 378-396 |
Linked-In: Design and Efficacy of Antibody Drug Conjugates in Oncology
Linked-In: Design and Efficacy of Antibody Drug Conjugates in Oncology |
|
https://doi.org/10.18632/oncotarget.924
Jonathan Feld,
Stefan K. Barta,
Carolina Schinke,
Ira Braunschweig,
Yiyu Zhou,
and Amit K. Verma
|
| 397-412 |
Tumorigenic potential of circulating prostate tumor cells
Tumorigenic potential of circulating prostate tumor cells |
|
https://doi.org/10.18632/oncotarget.895
Filipe LF. Carvalho,
Brian W. Simons,
Emmanuel S. Antonarakis,
Zeshaan Rasheed,
Nora Douglas,
Daniela Villegas,
William Matsui,
and David M. Berman
|
| 413-421 |
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone |
|
https://doi.org/10.18632/oncotarget.917
Miklos Jaszberenyi,
Andrew V Schally,
Norman L Block,
Mehrdad Nadji,
Irving Vidaurre,
Luca Szalontay,
and Ferenc G Rick
|
| 422-432 |
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo |
|
https://doi.org/10.18632/oncotarget.930
Shuang Yan,
Zhijie Li,
and Carol J Thiele
|
| 433-445 |
The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism
The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism |
|
https://doi.org/10.18632/oncotarget.872
Khoi Chu,
Kimberkey M. Boley,
Ricardo Moraes,
Sanford H. Barsky,
and Fredika M. Robertson
|
| 446-462 |
A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal
A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal |
|
https://doi.org/10.18632/oncotarget.886
Filip Janku,
Helen J. Huang,
Laura S. Angelo,
and Razelle Kurzrock
|
| 463-473 |
Nuclear DNA Methylation and Chromatin Condensation Phenotypes Are Distinct Between Normally Proliferating/Aging, Rapidly Growing/Immortal, and Senescent Cells
Nuclear DNA Methylation and Chromatin Condensation Phenotypes Are Distinct Between Normally Proliferating/Aging, Rapidly Growing/Immortal, and Senescent Cells |
|
https://doi.org/10.18632/oncotarget.942
Jin Ho Oh,
Arkadiusz Gertych,
and Jian Tajbakhsh
|
| 474-493 |
